Navigation Links
L'Oreal Paris Continues Passionate Commitment to Ovarian Cancer Research and Awareness Programs in 2008
Date:9/8/2008

es information about the disease and offers ways to help support the fight against ovarian cancer. In recognition of the nearly 22,000 women annually diagnosed with the disease, L'Oreal Paris hopes to draw 22,000 new visitors to the site during the month of September.

Additionally, L'Oreal Paris is partnering with EHE International to raise awareness for ovarian cancer. L'Oreal spokeswomen Kerry Washington and Eva Longoria Parker, have joined L'Oreal Paris in the fight against ovarian cancer and will be featured in a public service display on the Plaza in Rockefeller Center in New York City. The window will be on display during September in recognition of National Ovarian Cancer Awareness Month and seeks to educate passersby about the disease and its effects on the nearly 22,000 women that will be diagnosed each year. The window at 10 Rockefeller Plaza features a compelling reminder of the signs and symptoms of the disease.

-- Survivor Support Through Employee Engagement -- L'Oreal Paris will engage employees with a weeklong awareness campaign at their New York headquarters. L'Oreal Paris will host a series of events that will encourage and motivate employees to act as ambassadors of hope to raise awareness for ovarian cancer. Additionally, L'Oreal Paris will host a group of ovarian cancer survivors for a day of beauty at the L'Oreal Technical Center, for indulgence that resonates both inside and out.

-- L'Oreal Legends Gala -- The 2008 L'Oreal Legends Gala is a glamorous evening dedicated to hope and fundraising and will be held on November 10th in New York City at the American Museum of Natural History. The festive evening will unite the worlds of beauty, fashion and media and will include a cocktail reception, dinner, silent and live auctions and musical performances. Past attendees have included members of the L'Oreal Paris family including spokespeople: Diane Keaton, Andie MacDowell, Eva Longoria Parker, Dayle Haddon, Milla Jovovich and Ker
'/>"/>

SOURCE L'Oreal Paris
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
3. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
5. LOreal Paris Celebrates Ten Years of Hope and Healing
6. OCuSOFT Refutes Comparison Time-Kill Study Released by Advanced Vision Research
7. Global Summit on AIDS & The Church Calls for Public, Private and Parish Sectors To Unite in Response to Worldwide Pandemic: Pastor Rick and Kay Warren Host More Than 1,700 at Event Featuring International Dignitaries, Political Figures and International E
8. Diuretics excel in drug comparison trial involving hypertension/metabolic syndrome
9. Comparison of venlafaxine and SSRIs in the treatment of depression
10. Comparison of antipsychotic treatments in adolescents with schizophrenia
11. Comparison of anticoagulants for angioplasty show similar outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)... LAKES, N.J., Nov. 21 To...edical intervention in treating 88 percent of pati... of Americans treated for a chronic condition acco...ng and 75 percent of all medical costs. A proprie... by Medco Health Solutions, Inc. (NYSE: MHS ) si...
(Date:11/21/2008)...nts in mice find running increases production of n...althDay News) -- In experiments in mice, exercise ...f brain stem cells usually seen with aging, Taiwan...ration of the brain,s ability to stave off aging a...a neurochemical that is essential for the producti...
(Date:11/21/2008)..., Nov. 21 /PRNewswire/ -- For the second year i..., McCann Healthcare Worldwide,s agency network wo...rk at the 22nd annual international RX Club Show. ...y offices won a total of 59 RX Club Awards of Exce...ng McCann Healthcare Worldwide agencies include Ca...
(Date:11/21/2008)...Nov. 21 Innerscope Research(TM), a...ializing in Emotional Response Measurement,annou... will strengthen the,company,s research and devel...es. , The three appointments, who deliver a...y Gill as Chief Financial Officer and Vice Preside...
Breaking Medicine News(10 mins):Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Exercise Keeps the Brain Young 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2
...orn to women with high levels of lead in their bon... babies exposed to lead from sources like old pain...the journal Pediatrics, they said this type of lea... health problem, in view of the long residence tim...
...t with medications can reduce abdominal fat in peo...rsity of Texas have been looking into the effect t...2 diabetes.// They studied 10 people with the cond... After this time body weight had, on the whole, in...
...ect people who are at high risk of suffering a str...is cheap enough to be used by opticians and GPs to...cell death due to bleeding from damaged blood vess...e in high-risk patients are available, so doctors ...
...tective substances, produced by the body in stress... TB bacteria, researchers in the UK report. Accord...ature Medicine,// these heat-shock proteins, which...cells survive stressful times and bolster the immu...
Other Medicine News:
(Date:11/20/2008)..., , , , PHILADELPHIA, Nov. 20 /PRNe... today announced that the United States Food and D...val for PROMACTA(R) (eltrombopag) for the treatmen...une (idiopathic) thrombocytopenic purpura (ITP) wh...oids, immunoglobulins or splenectomy. The approval...
(Date:11/20/2008)... REINACH, Switzerland, November 20 /PRNewswire-F...hat the Anti-infective Drugs Advisory Committee of...voted 17 to 2 against the,approval of intravenous...for,the treatment of patients with complicated sk...ing those caused by methicillin-resistant Staphylo...
(Date:11/20/2008)...MERYVILLE, Calif., Nov. 20 /PRNewswire-FirstCall/ ...company will present results from the Phase 1B,cl...nced metastatic breast,cancer, BZL101, at the Soc...l,Conference in Atlanta, Georgia. The Company,s ...bstract and will be presented as a part of the Bes...
(Date:11/20/2008)...AMBRIDGE, Mass., Nov. 20 Radius He... an additional $15 million to its second instituti...vestment to $82.5 million and the total amount rai...n. All existing institutional investors participat...ic Fund and including MPM Capital, The Wellcome Tr...
Breaking Medicine Technology:FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 1Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 2Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 3Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative 8600 4Most Off Label Cancer Drug Use for Palliative Care 27727 1Most Off Label Cancer Drug Use for Palliative Care 27727 2The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 1The Beryl Companies Launches CARE Calls Program in Five Hospitals Across U S 27723 2Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 1Accuray Incorporated to Speak at Oppenheimer Healthcare Conference 27719 2
...ique suggests how lithium works as a,therapeutic ,...CLA have shown,that lithium, long the standard tre...of gray matter in the brains of patients with,the ...issue of the journal,Biological Psychiatry and is ...clinical neuropsychologist and assistant,professor...
... Oncology Portfolio, SOUTH SAN FRANCISCO, Calif., ...rmaceuticals, Inc. today,announced the presentatio...mall molecule inhibitors of select kinases as,pote...d other,disorders. Rigel scientists will give the ...th to 18th (see list below) at the,upcoming meetin...
Other Medicine Technology:UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 2UCLA: Lithium Builds Gray Matter in Bipolar Brains, UCLA Study,Shows 3Rigel to Present New Research Programs at AACR Meeting 2Rigel to Present New Research Programs at AACR Meeting 3Rigel to Present New Research Programs at AACR Meeting 4Rigel to Present New Research Programs at AACR Meeting 5
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays.
...e PhD System has the flexibility to accommodate EI...s with low to high volume workloads, the unique mo...g. Through networking, one to ten workstations can...ers can switch a single workstation from EIA to IF...
...idelberg Engineering GmbH, the leading developer o...nnounced the introduction of the Heidelberg Retina...ts flagship product for the assessment, diagnosis ...ssor, the HRT3 uses laser technology to produce a ...
Medicine Products: